Literature DB >> 7416528

Pharmacokinetics of high-dose thiopental used in cerebral resuscitation.

D R Stanski, F G Mihm, M H Rosenthal, S M Kalman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7416528     DOI: 10.1097/00000542-198008000-00012

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  7 in total

1.  Stereoselective interaction of thiopentone enantiomers with the GABA(A) receptor.

Authors:  D J Cordato; M Chebib; L E Mather; G K Herkes; G A Johnston
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

Review 2.  Pharmacodynamics and pharmacokinetics of thiopental.

Authors:  H Russo; F Bressolle
Journal:  Clin Pharmacokinet       Date:  1998-08       Impact factor: 6.447

3.  Time-dependent pharmacokinetics of high dose thiopental infusion in intensive care patients.

Authors:  H Russo; M P Dubboin; F Bressolle; S Urien
Journal:  Pharm Res       Date:  1997-11       Impact factor: 4.200

4.  Pharmacokinetics of thiopental after single and multiple intravenous doses in critical care patients.

Authors:  H Russo; J Brès; M P Duboin; B Roquefeuil
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

5.  Evaluation of infusion regimens for thiopentone as a primary anaesthetic agent.

Authors:  D P Crankshaw; N E Edwards; G L Blackman; M D Boyd; H N Chan; D J Morgan
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  Interaction of thiopental with esomeprazole in critically ill patients.

Authors:  Amélie Marsot; Françoise Goirand; Nadine Milési; Monique Dumas; Audrey Boulamery; Nicolas Simon
Journal:  Eur J Clin Pharmacol       Date:  2013-05-30       Impact factor: 2.953

Review 7.  Comparison of Intravenous Anesthetic Agents for the Treatment of Refractory Status Epilepticus.

Authors:  Michael E Reznik; Karen Berger; Jan Claassen
Journal:  J Clin Med       Date:  2016-05-19       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.